<pages>
<page id="1" bbox="0.000,0.000,720.000,540.000" rotate="0">
<title id="0" bbox="85.992,338.557,644.900,488.227" size="44.048" unique_id="0">Second Meeting of the  
FDA/ACPS Process Analytical  
Technology: Closing Remarks <textline bbox="160.150,444.187,570.867,488.227" font="TimesNewRomanPSMT" ncolour="0" size="44.040" colourspace="DeviceGray">Second Meeting of the  </textline>
<textline bbox="85.992,391.382,644.900,435.446" font="TimesNewRomanPSMT" ncolour="0" size="44.064" colourspace="DeviceGray">FDA/ACPS Process Analytical  </textline>
<textline bbox="92.472,338.557,627.338,382.597" font="TimesNewRomanPSMT" ncolour="0" size="44.040" colourspace="DeviceGray">Technology: Closing Remarks </textline>
</title>
<normal_text id="1" bbox="139.270,54.183,580.493,224.489" size="32.04" unique_id="1">Ajaz S. Hussain, Ph.D. 
Deputy Director  
Office of Pharmaceutical Sciences 
CDER, FDA <textline bbox="212.740,192.449,507.156,224.489" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">Ajaz S. Hussain, Ph.D. </textline>
<textline bbox="255.460,146.369,472.531,178.409" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">Deputy Director  </textline>
<textline bbox="139.270,100.259,580.493,132.299" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">Office of Pharmaceutical Sciences </textline>
<textline bbox="277.300,54.183,442.851,86.223" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">CDER, FDA </textline>
</normal_text>
</page>
<page id="2" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[252.94, 445.387, 467.062, 489.427]">
<title id="0" bbox="252.940,445.387,467.062,489.427" size="44.04" unique_id="0">A Reminder <textline bbox="252.940,445.387,467.062,489.427" font="TimesNewRomanPSMT" ncolour="0" size="44.040" colourspace="DeviceGray">A Reminder </textline>
</title>
<enlisting bbox="61.224,36.663,664.222,410.558" unique_id="['1', '2', '3']">&#8226; Quality of drug products available to the US  patients is good 
&#8211; The current quality assurance system  (specifications/controls; GMP; testing,..) is able  
to prevent the release of low quality product 
&#8226; Very few Class I recalls due to quality problems 
&#8226; Current level of process understanding is  
low and, therefore, requires a very high  
level of scrutiny and rejecting product of  
unacceptable  <normal_text id="1" bbox="61.224,378.494,664.222,410.558" size="32.064" unique_id="1">&#8226; Quality of drug products available to the US  <textline bbox="61.224,378.494,664.222,410.558" font="TimesNewRomanPSMT" ncolour="0" size="32.064" colourspace="DeviceGray">&#8226; Quality of drug products available to the US  </textline>
</normal_text>
<normal_text id="2" bbox="88.224,299.791,541.221,372.109" size="30.0" unique_id="2">patients is good 
&#8211; The current quality assurance system  <textline bbox="88.224,340.069,289.403,372.109" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">patients is good </textline>
<textline bbox="97.224,299.791,541.221,327.751" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8211; The current quality assurance system  </textline>
</normal_text>
<normal_text id="3" bbox="61.224,36.663,661.858,294.169" size="29.729142857142854" unique_id="3">(specifications/controls; GMP; testing,..) is able  
to prevent the release of low quality product 
&#8226; Very few Class I recalls due to quality problems 
&#8226; Current level of process understanding is  
low and, therefore, requires a very high  
level of scrutiny and rejecting product of  
unacceptable  <textline bbox="119.780,266.185,661.858,294.169" font="TimesNewRomanPSMT" ncolour="0" size="27.984" colourspace="DeviceGray">(specifications/controls; GMP; testing,..) is able  </textline>
<textline bbox="119.780,232.571,614.392,260.531" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">to prevent the release of low quality product </textline>
<textline bbox="133.220,197.906,611.948,221.906" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">&#8226; Very few Class I recalls due to quality problems </textline>
<textline bbox="61.224,151.889,621.530,183.929" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Current level of process understanding is  </textline>
<textline bbox="88.224,113.459,601.120,145.499" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">low and, therefore, requires a very high  </textline>
<textline bbox="88.224,75.063,618.742,107.103" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">level of scrutiny and rejecting product of  </textline>
<textline bbox="88.224,36.663,263.979,68.703" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">unacceptable  </textline>
</normal_text>
</enlisting></page>
<page id="3" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[201.56000000000003, 462.935, 518.4213333333333, 504.25499999999994]">
<title id="0" bbox="175.870,471.709,544.101,511.669" size="39.96" unique_id="0">Process Understanding <textline bbox="175.870,471.709,544.101,511.669" font="TimesNewRomanPSMT" ncolour="0" size="39.960" colourspace="DeviceGray">Process Understanding </textline>
</title>
<enlisting bbox="43.2,22.978,681.848,452.539" unique_id="['1', '  2', '  4', '  5', ' 3', '6']">&#8226; Pharmaceuticals are complex, multivariate,  physico-chemical systems 
&#8211; Often treated (during development) as a univariate  &#8211; Materials not well characterized -physical attributes 
&#8211; Equipment selection &#8211; tradition 
&#8211; Process factors &#8211; limited information (optimal?) &#8226; Development &#8220;time crunch&#8221; 
&#8226; Post approval changes require regulatory  <normal_text id="1" bbox="43.200,420.499,632.238,452.539" size="32.04" unique_id="1">&#8226; Pharmaceuticals are complex, multivariate,  <textline bbox="43.200,420.499,632.238,452.539" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Pharmaceuticals are complex, multivariate,  </textline>
</normal_text>
<normal_text id="2" bbox="70.224,341.791,674.261,414.158" size="30.012" unique_id="2">physico-chemical systems 
&#8211; Often treated (during development) as a univariate  <textline bbox="70.224,382.094,405.917,414.158" font="TimesNewRomanPSMT" ncolour="0" size="32.064" colourspace="DeviceGray">physico-chemical systems </textline>
<textline bbox="79.224,341.791,674.261,369.751" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8211; Often treated (during development) as a univariate  </textline>
</normal_text>
<normal_text id="4" bbox="79.224,153.611,681.848,262.211" size="27.959999999999997" unique_id="4">&#8211; Materials not well characterized -physical attributes 
&#8211; Equipment selection &#8211; tradition 
&#8211; Process factors &#8211; limited information (optimal?) <textline bbox="79.224,234.251,681.848,262.211" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8211; Materials not well characterized -physical attributes </textline>
<textline bbox="79.224,193.931,453.794,221.891" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8211; Equipment selection &#8211; tradition </textline>
<textline bbox="79.224,153.611,640.189,181.571" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8211; Process factors &#8211; limited information (optimal?) </textline>
</normal_text>
<normal_text id="5" bbox="43.200,61.383,602.985,139.499" size="32.04" unique_id="5">&#8226; Development &#8220;time crunch&#8221; 
&#8226; Post approval changes require regulatory  <textline bbox="43.200,107.459,431.443,139.499" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Development &#8220;time crunch&#8221; </textline>
<textline bbox="43.200,61.383,602.985,93.423" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Post approval changes require regulatory  </textline>
</normal_text>
<normal_text id="3" bbox="101.780,274.591,595.277,336.151" size="27.96" unique_id="3">system (one-factor-at-a-time, trial and error  
experimentation <textline bbox="101.780,308.191,595.277,336.151" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">system (one-factor-at-a-time, trial and error  </textline>
<textline bbox="101.780,274.591,283.464,302.551" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">experimentation </textline>
</normal_text>
<normal_text id="6" bbox="70.224,22.978,189.662,55.042" size="32.064" unique_id="6">oversight <textline bbox="70.224,22.978,189.662,55.042" font="TimesNewRomanPSMT" ncolour="0" size="32.064" colourspace="DeviceGray">oversight </textline>
</normal_text>
</enlisting></page>
<page id="4" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[136.996, 405.12300000000005, 587.8341666666666, 507.962]">
<title id="0" bbox="72.432,347.311,657.247,511.669" size="36.966" unique_id="0">Limited, but sufficient for approval,  
process understanding  
can lead to &#8230;.. 
&#8226; Risk of  <textline bbox="72.432,471.709,657.247,511.669" font="TimesNewRomanPSMT" ncolour="0" size="39.960" colourspace="DeviceGray">Limited, but sufficient for approval,  </textline>
<textline bbox="181.420,423.709,548.253,463.669" font="TimesNewRomanPSMT" ncolour="0" size="39.960" colourspace="DeviceGray">process understanding  </textline>
<textline bbox="238.420,375.703,481.523,415.687" font="TimesNewRomanPSMT" ncolour="0" size="39.984" colourspace="DeviceGray">can lead to &#8230;.. </textline>
<textline bbox="373.270,347.311,488.819,375.271" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8226; Risk of  </textline>
</title>
<footer id="9" bbox="109.220,23.016,578.804,41.016" size="18.0" unique_id="9">Note - Quality is the foundation for Safety &amp; Efficacy decisions <textline bbox="109.220,23.016,578.804,41.016" font="TimesNewRomanPS-BoldItalicMT" ncolour="0" size="18.000" colourspace="DeviceGray">Note - Quality is the foundation for Safety &amp; Efficacy decisions </textline>
</footer>
<enlisting bbox="31.2,93.72,348.144,375.271" unique_id="['1', ' 3', '2']">&#8226; Low process capability 
&#8211; Scrap, Rework, or Recall 
&#8211; Protracted production  
cycle times and low  
capacity utilization 
&#8211; Resolution of process  &#8211; High cost of compliance <normal_text id="1" bbox="31.200,185.906,331.704,375.271" size="24.664" unique_id="1">&#8226; Low process capability 
&#8211; Scrap, Rework, or Recall 
&#8211; Protracted production  
cycle times and low  
capacity utilization 
&#8211; Resolution of process  <textline bbox="31.200,347.311,318.116,375.271" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8226; Low process capability </textline>
<textline bbox="67.224,312.646,331.704,336.646" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">&#8211; Scrap, Rework, or Recall </textline>
<textline bbox="67.224,278.086,304.368,302.086" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">&#8211; Protracted production  </textline>
<textline bbox="89.784,249.281,286.853,273.305" font="TimesNewRomanPSMT" ncolour="0" size="24.024" colourspace="DeviceGray">cycle times and low  </textline>
<textline bbox="89.784,220.466,272.832,244.466" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">capacity utilization </textline>
<textline bbox="67.224,185.906,303.648,209.906" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">&#8211; Resolution of process  </textline>
</normal_text>
<normal_text id="3" bbox="67.224,93.720,324.960,117.720" size="24.0" unique_id="3">&#8211; High cost of compliance <textline bbox="67.224,93.720,324.960,117.720" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">&#8211; High cost of compliance </textline>
</normal_text>
<normal_text id="2" bbox="89.784,128.301,348.144,181.106" size="24.012" unique_id="2">related problems slow and  
difficult  <textline bbox="89.784,157.106,348.144,181.106" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">related problems slow and  </textline>
<textline bbox="89.784,128.301,172.643,152.325" font="TimesNewRomanPSMT" ncolour="0" size="24.024" colourspace="DeviceGray">difficult  </textline>
</normal_text>
</enlisting><enlisting bbox="409.27,59.16,681.55,336.646" unique_id="['4', '  5', '  7', ' 6', '8']">&#8211; Drug shortages 
&#8211; Releasing a poor quality  product 
&#8211; Recalls 
&#8211; Delay in approval of new  &#8211; Quality problems  <normal_text id="4" bbox="409.270,278.086,671.710,336.646" size="24.0" unique_id="4">&#8211; Drug shortages 
&#8211; Releasing a poor quality  <textline bbox="409.270,312.646,577.894,336.646" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">&#8211; Drug shortages </textline>
<textline bbox="409.270,278.086,671.710,302.086" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">&#8211; Releasing a poor quality  </textline>
</normal_text>
<normal_text id="5" bbox="409.270,180.146,681.550,273.305" size="24.008" unique_id="5">product 
&#8211; Recalls 
&#8211; Delay in approval of new  <textline bbox="431.830,249.281,505.223,273.305" font="TimesNewRomanPSMT" ncolour="0" size="24.024" colourspace="DeviceGray">product </textline>
<textline bbox="409.270,214.706,502.534,238.706" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">&#8211; Recalls </textline>
<textline bbox="409.270,180.146,681.550,204.146" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">&#8211; Delay in approval of new  </textline>
</normal_text>
<normal_text id="7" bbox="409.270,116.781,604.971,140.805" size="24.024" unique_id="7">&#8211; Quality problems  <textline bbox="409.270,116.781,604.971,140.805" font="TimesNewRomanPSMT" ncolour="0" size="24.024" colourspace="DeviceGray">&#8211; Quality problems  </textline>
</normal_text>
<normal_text id="6" bbox="431.830,151.346,485.158,175.346" size="24.0" unique_id="6">drugs <textline bbox="431.830,151.346,485.158,175.346" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">drugs </textline>
</normal_text>
<normal_text id="8" bbox="431.830,59.160,680.254,111.960" size="24.0" unique_id="8">confounding clinical trial  
data <textline bbox="431.830,87.960,680.254,111.960" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">confounding clinical trial  </textline>
<textline bbox="431.830,59.160,471.814,83.160" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">data </textline>
</normal_text>
</enlisting></page>
<page id="5" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[128.9296, 401.0666, 598.3349000000001, 501.508]">
<title id="0" bbox="116.830,394.982,614.086,491.827" size="44.052" unique_id="0">Approaches for minimizing  
&#8220;risks&#8221; <textline bbox="116.830,447.787,614.086,491.827" font="TimesNewRomanPSMT" ncolour="0" size="44.040" colourspace="DeviceGray">Approaches for minimizing  </textline>
<textline bbox="298.780,394.982,421.234,439.046" font="TimesNewRomanPSMT" ncolour="0" size="44.064" colourspace="DeviceGray">&#8220;risks&#8221; </textline>
</title>
<enlisting bbox="61.224,71.745,653.089,374.509" unique_id="['1', ' 2', ' 4', ' 5', '3']">&#8226; Option #1 Increase the level of FDA  scrutiny 
&#8211; FDA resources limited, while number of  &#8226; Option #2 Increase the level of process  understanding (prevention option) 
&#8211; PAT is a model  <normal_text id="1" bbox="61.224,342.469,562.064,374.509" size="32.04" unique_id="1">&#8226; Option #1 Increase the level of FDA  <textline bbox="61.224,342.469,562.064,374.509" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Option #1 Increase the level of FDA  </textline>
</normal_text>
<normal_text id="2" bbox="88.224,263.785,578.997,336.109" size="30.012" unique_id="2">scrutiny 
&#8211; FDA resources limited, while number of  <textline bbox="88.224,304.069,191.553,336.109" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">scrutiny </textline>
<textline bbox="97.224,263.785,578.997,291.769" font="TimesNewRomanPSMT" ncolour="0" size="27.984" colourspace="DeviceGray">&#8211; FDA resources limited, while number of  </textline>
</normal_text>
<normal_text id="4" bbox="61.224,150.449,603.938,182.489" size="32.04" unique_id="4">&#8226; Option #2 Increase the level of process  <textline bbox="61.224,150.449,603.938,182.489" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Option #2 Increase the level of process  </textline>
</normal_text>
<normal_text id="5" bbox="88.224,71.745,525.634,144.059" size="30.0" unique_id="5">understanding (prevention option) 
&#8211; PAT is a model  <textline bbox="88.224,112.019,525.634,144.059" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">understanding (prevention option) </textline>
<textline bbox="97.224,71.745,295.313,99.705" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8211; PAT is a model  </textline>
</normal_text>
<normal_text id="3" bbox="119.780,196.571,653.089,258.131" size="27.96" unique_id="3">products and manufacturing establishments are  
increasing <textline bbox="119.780,230.171,653.089,258.131" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">products and manufacturing establishments are  </textline>
<textline bbox="119.780,196.571,234.752,224.531" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">increasing </textline>
</normal_text>
</enlisting></page>
<page id="6" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[160.1064, 415.8400666666667, 564.7199333333333, 497.481]">
<title id="0" bbox="222.460,445.387,497.490,489.427" size="44.04" unique_id="0">Current System <textline bbox="222.460,445.387,497.490,489.427" font="TimesNewRomanPSMT" ncolour="0" size="44.040" colourspace="DeviceGray">Current System </textline>
</title>
<enlisting bbox="61.224,38.583,652.23,410.558" unique_id="['1', '  2', '  4', '  6', '  7', '  8', ' 3', '5']">&#8226; Strict adherence to SOP&#8217;s and all other  
documented procedures CRITICAL &#8226; Pre-specified Time and Testing are used to  &#8226; Univariate assessment - not a SYSTEMS  &#8226; Learning essentially stops after &#8220;validation&#8221; &#8211; inability to &#8220;connect-the-dots&#8221;  &#8226; Not conducive to continues improvement <normal_text id="1" bbox="61.224,340.069,592.270,410.558" size="32.052" unique_id="1">&#8226; Strict adherence to SOP&#8217;s and all other  
documented procedures CRITICAL <textline bbox="61.224,378.494,592.270,410.558" font="TimesNewRomanPSMT" ncolour="0" size="32.064" colourspace="DeviceGray">&#8226; Strict adherence to SOP&#8217;s and all other  </textline>
<textline bbox="88.224,340.069,548.799,372.109" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">documented procedures CRITICAL </textline>
</normal_text>
<normal_text id="2" bbox="61.224,293.989,640.931,326.029" size="32.04" unique_id="2">&#8226; Pre-specified Time and Testing are used to  <textline bbox="61.224,293.989,640.931,326.029" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Pre-specified Time and Testing are used to  </textline>
</normal_text>
<normal_text id="4" bbox="61.224,209.489,623.669,241.529" size="32.04" unique_id="4">&#8226; Univariate assessment - not a SYSTEMS  <textline bbox="61.224,209.489,623.669,241.529" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Univariate assessment - not a SYSTEMS  </textline>
</normal_text>
<normal_text id="6" bbox="61.224,125.004,652.230,157.068" size="32.064" unique_id="6">&#8226; Learning essentially stops after &#8220;validation&#8221; <textline bbox="61.224,125.004,652.230,157.068" font="TimesNewRomanPSMT" ncolour="0" size="32.064" colourspace="DeviceGray">&#8226; Learning essentially stops after &#8220;validation&#8221; </textline>
</normal_text>
<normal_text id="7" bbox="97.224,84.705,467.096,112.665" size="27.96" unique_id="7">&#8211; inability to &#8220;connect-the-dots&#8221;  <textline bbox="97.224,84.705,467.096,112.665" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8211; inability to &#8220;connect-the-dots&#8221;  </textline>
</normal_text>
<normal_text id="8" bbox="61.224,38.583,618.390,70.623" size="32.04" unique_id="8">&#8226; Not conducive to continues improvement <textline bbox="61.224,38.583,618.390,70.623" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Not conducive to continues improvement </textline>
</normal_text>
<normal_text id="3" bbox="88.224,255.584,389.914,287.648" size="32.064" unique_id="3">document conformance <textline bbox="88.224,255.584,389.914,287.648" font="TimesNewRomanPSMT" ncolour="0" size="32.064" colourspace="DeviceGray">document conformance </textline>
</normal_text>
<normal_text id="5" bbox="88.224,171.089,475.043,203.129" size="32.04" unique_id="5">approach for quality decisions <textline bbox="88.224,171.089,475.043,203.129" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">approach for quality decisions </textline>
</normal_text>
</enlisting></page>
<page id="7" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[186.63028571428572, 431.1391904761905, 536.7799523809523, 502.037]">
<title id="0" bbox="252.940,469.387,466.930,513.427" size="44.04" unique_id="0">PAT System <textline bbox="252.940,469.387,466.930,513.427" font="TimesNewRomanPSMT" ncolour="0" size="44.040" colourspace="DeviceGray">PAT System </textline>
</title>
<enlisting bbox="67.224,24.178,632.995,434.539" unique_id="['1', '2', '3', '4']">&#8226; Performance based assessments used to  
confirm conformance throughout the  
process (prevent manufacture of  
unacceptable end product quality)  &#8226; SYSTEMS approach for quality decisions 
&#8226; Learning and validation continuos  &#8211; Dots connected  &#8226; Conducive to continues improvement  
&#8226; Strict adherence to SOP&#8217;s and all other  
documented procedures CRITICAL <normal_text id="1" bbox="67.224,287.269,609.203,434.539" size="32.046" unique_id="1">&#8226; Performance based assessments used to  
confirm conformance throughout the  
process (prevent manufacture of  
unacceptable end product quality)  <textline bbox="67.224,402.499,609.203,434.539" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Performance based assessments used to  </textline>
<textline bbox="94.224,364.094,574.030,396.158" font="TimesNewRomanPSMT" ncolour="0" size="32.064" colourspace="DeviceGray">confirm conformance throughout the  </textline>
<textline bbox="94.224,325.669,515.486,357.709" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">process (prevent manufacture of  </textline>
<textline bbox="94.224,287.269,537.363,319.309" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">unacceptable end product quality)  </textline>
</normal_text>
<normal_text id="2" bbox="67.224,195.089,632.995,273.248" size="32.052" unique_id="2">&#8226; SYSTEMS approach for quality decisions 
&#8226; Learning and validation continuos  <textline bbox="67.224,241.184,632.995,273.248" font="TimesNewRomanPSMT" ncolour="0" size="32.064" colourspace="DeviceGray">&#8226; SYSTEMS approach for quality decisions </textline>
<textline bbox="67.224,195.089,540.733,227.129" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Learning and validation continuos  </textline>
</normal_text>
<normal_text id="3" bbox="103.220,154.811,306.010,182.771" size="27.96" unique_id="3">&#8211; Dots connected  <textline bbox="103.220,154.811,306.010,182.771" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8211; Dots connected  </textline>
</normal_text>
<normal_text id="4" bbox="67.224,24.178,598.245,140.699" size="32.048" unique_id="4">&#8226; Conducive to continues improvement  
&#8226; Strict adherence to SOP&#8217;s and all other  
documented procedures CRITICAL <textline bbox="67.224,108.659,583.347,140.699" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Conducive to continues improvement  </textline>
<textline bbox="67.224,62.583,598.245,94.623" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Strict adherence to SOP&#8217;s and all other  </textline>
<textline bbox="94.224,24.178,554.791,56.242" font="TimesNewRomanPSMT" ncolour="0" size="32.064" colourspace="DeviceGray">documented procedures CRITICAL </textline>
</normal_text>
</enlisting></page>
<page id="8" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[178.39021428571428, 422.0998928571429, 546.8747142857143, 499.48449999999997]">
<title id="0" bbox="153.670,394.982,577.159,491.827" size="44.052" unique_id="0">Emerging PAT Guiding  
Principles <textline bbox="153.670,447.787,577.159,491.827" font="TimesNewRomanPSMT" ncolour="0" size="44.040" colourspace="DeviceGray">Emerging PAT Guiding  </textline>
<textline bbox="271.900,394.982,448.156,439.046" font="TimesNewRomanPSMT" ncolour="0" size="44.064" colourspace="DeviceGray">Principles </textline>
</title>
<enlisting bbox="61.224,38.625,610.924,386.509" unique_id="['1', '   2', '   4', '   5', '   8', '  3', ' 6', '7']">&#8226; NDA/ANDA &#8211; Should not prolong review times due to  &#8211; Early meetings with PAT reviewer 
&#8226; Expert technical support available 
&#8226; GMP issues identified and discussed with PAT  &#8226; Possible - reviewer participates in pre-approval  &#8211; Consider interim specifications (PAT) <normal_text id="1" bbox="61.224,354.469,259.125,386.509" size="32.04" unique_id="1">&#8226; NDA/ANDA <textline bbox="61.224,354.469,259.125,386.509" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; NDA/ANDA </textline>
</normal_text>
<normal_text id="2" bbox="97.224,314.191,569.489,342.151" size="27.96" unique_id="2">&#8211; Should not prolong review times due to  <textline bbox="97.224,314.191,569.489,342.151" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8211; Should not prolong review times due to  </textline>
</normal_text>
<normal_text id="4" bbox="97.224,171.026,602.660,268.249" size="25.328000000000003" unique_id="4">&#8211; Early meetings with PAT reviewer 
&#8226; Expert technical support available 
&#8226; GMP issues identified and discussed with PAT  <textline bbox="97.224,240.265,503.441,268.249" font="TimesNewRomanPSMT" ncolour="0" size="27.984" colourspace="DeviceGray">&#8211; Early meetings with PAT reviewer </textline>
<textline bbox="133.220,205.586,478.076,229.586" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">&#8226; Expert technical support available </textline>
<textline bbox="133.220,171.026,602.660,195.026" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">&#8226; GMP issues identified and discussed with PAT  </textline>
</normal_text>
<normal_text id="5" bbox="133.220,107.636,610.924,131.636" size="24.0" unique_id="5">&#8226; Possible - reviewer participates in pre-approval  <textline bbox="133.220,107.636,610.924,131.636" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">&#8226; Possible - reviewer participates in pre-approval  </textline>
</normal_text>
<normal_text id="8" bbox="97.224,38.625,541.920,66.585" size="27.96" unique_id="8">&#8211; Consider interim specifications (PAT) <textline bbox="97.224,38.625,541.920,66.585" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8211; Consider interim specifications (PAT) </textline>
</normal_text>
<normal_text id="3" bbox="119.780,280.591,340.944,308.551" size="27.96" unique_id="3">introduction of PAT <textline bbox="119.780,280.591,340.944,308.551" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">introduction of PAT </textline>
</normal_text>
<normal_text id="6" bbox="151.220,142.226,239.276,166.226" size="24.0" unique_id="6">inspector <textline bbox="151.220,142.226,239.276,166.226" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">inspector </textline>
</normal_text>
<normal_text id="7" bbox="151.220,78.840,256.052,102.840" size="24.0" unique_id="7">inspection  <textline bbox="151.220,78.840,256.052,102.840" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">inspection  </textline>
</normal_text>
</enlisting></page>
<page id="9" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[172.89683333333332, 421.4081388888889, 553.6045555555555, 503.1161666666667]">
<title id="0" bbox="153.670,418.987,577.159,515.827" size="44.04" unique_id="0">Emerging PAT Guiding  
Principles <textline bbox="153.670,471.787,577.159,515.827" font="TimesNewRomanPSMT" ncolour="0" size="44.040" colourspace="DeviceGray">Emerging PAT Guiding  </textline>
<textline bbox="271.900,418.987,448.060,463.027" font="TimesNewRomanPSMT" ncolour="0" size="44.040" colourspace="DeviceGray">Principles </textline>
</title>
<enlisting bbox="67.224,177.026,642.117,392.558" unique_id="['1', '2', '3', '4', '5']">&#8226; Post-Approval &#8211; Company collects data to establish PAT proof  of concept or suitability 
&#8226; Communication with FDA an option &#8211; PAT meeting with PAT Team &#8226; Goals and Objectives of this meeting  <normal_text id="1" bbox="67.224,360.494,281.174,392.558" size="32.064" unique_id="1">&#8226; Post-Approval <textline bbox="67.224,360.494,281.174,392.558" font="TimesNewRomanPSMT" ncolour="0" size="32.064" colourspace="DeviceGray">&#8226; Post-Approval </textline>
</normal_text>
<normal_text id="2" bbox="103.220,320.191,642.117,348.151" size="27.96" unique_id="2">&#8211; Company collects data to establish PAT proof  <textline bbox="103.220,320.191,642.117,348.151" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8211; Company collects data to establish PAT proof  </textline>
</normal_text>
<normal_text id="3" bbox="125.780,251.921,508.979,314.551" size="25.992" unique_id="3">of concept or suitability 
&#8226; Communication with FDA an option <textline bbox="125.780,286.591,392.323,314.551" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">of concept or suitability </textline>
<textline bbox="139.220,251.921,508.979,275.945" font="TimesNewRomanPSMT" ncolour="0" size="24.024" colourspace="DeviceGray">&#8226; Communication with FDA an option </textline>
</normal_text>
<normal_text id="4" bbox="103.220,211.691,448.103,239.651" size="27.96" unique_id="4">&#8211; PAT meeting with PAT Team <textline bbox="103.220,211.691,448.103,239.651" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8211; PAT meeting with PAT Team </textline>
</normal_text>
<normal_text id="5" bbox="139.220,177.026,518.132,201.026" size="24.0" unique_id="5">&#8226; Goals and Objectives of this meeting  <textline bbox="139.220,177.026,518.132,201.026" font="TimesNewRomanPSMT" ncolour="0" size="24.000" colourspace="DeviceGray">&#8226; Goals and Objectives of this meeting  </textline>
</normal_text>
</enlisting><enlisting bbox="175.22,42.495,639.541,168.161" unique_id="['6', '7']">&#8211; Consensus on how to introduce PAT on an existing line  and questions to be addressed (data collection) for  
validation 
&#8211; Safe harbor 
&#8211; Submission and inspection strategy <normal_text id="6" bbox="175.220,148.121,639.541,168.161" size="20.04" unique_id="6">&#8211; Consensus on how to introduce PAT on an existing line  <textline bbox="175.220,148.121,639.541,168.161" font="TimesNewRomanPSMT" ncolour="0" size="20.040" colourspace="DeviceGray">&#8211; Consensus on how to introduce PAT on an existing line  </textline>
</normal_text>
<normal_text id="7" bbox="175.220,42.495,599.125,144.180" size="20.046" unique_id="7">and questions to be addressed (data collection) for  
validation 
&#8211; Safe harbor 
&#8211; Submission and inspection strategy <textline bbox="193.250,124.116,599.125,144.180" font="TimesNewRomanPSMT" ncolour="0" size="20.064" colourspace="DeviceGray">and questions to be addressed (data collection) for  </textline>
<textline bbox="193.250,100.091,273.350,120.131" font="TimesNewRomanPSMT" ncolour="0" size="20.040" colourspace="DeviceGray">validation </textline>
<textline bbox="175.220,71.295,286.155,91.335" font="TimesNewRomanPSMT" ncolour="0" size="20.040" colourspace="DeviceGray">&#8211; Safe harbor </textline>
<textline bbox="175.220,42.495,475.574,62.535" font="TimesNewRomanPSMT" ncolour="0" size="20.040" colourspace="DeviceGray">&#8211; Submission and inspection strategy </textline>
</normal_text>
</enlisting></page>
<page id="10" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[169.05146666666664, 420.9239111111111, 558.3154444444444, 505.65833333333336]">
<title id="0" bbox="153.670,418.987,577.159,515.827" size="44.04" unique_id="0">Emerging PAT Guiding  
Principles <textline bbox="153.670,471.787,577.159,515.827" font="TimesNewRomanPSMT" ncolour="0" size="44.040" colourspace="DeviceGray">Emerging PAT Guiding  </textline>
<textline bbox="271.900,418.987,448.060,463.027" font="TimesNewRomanPSMT" ncolour="0" size="44.040" colourspace="DeviceGray">Principles </textline>
</title>
<enlisting bbox="67.224,133.925,642.281,392.558" unique_id="['1', '  2', '  4', ' 3', '5']">&#8226; FDA - Higher level of training,  communication, and systems approach 
&#8211; CDER/ORA team approach 
&#8211; Minimal reliance on Prior Approval  &#8211; Increased emphasis on underlying science,  <normal_text id="1" bbox="67.224,360.494,501.191,392.558" size="32.064" unique_id="1">&#8226; FDA - Higher level of training,  <textline bbox="67.224,360.494,501.191,392.558" font="TimesNewRomanPSMT" ncolour="0" size="32.064" colourspace="DeviceGray">&#8226; FDA - Higher level of training,  </textline>
</normal_text>
<normal_text id="2" bbox="94.224,241.465,590.652,354.109" size="29.328000000000003" unique_id="2">communication, and systems approach 
&#8211; CDER/ORA team approach 
&#8211; Minimal reliance on Prior Approval  <textline bbox="94.224,322.069,590.652,354.109" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">communication, and systems approach </textline>
<textline bbox="103.220,281.791,436.472,309.751" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8211; CDER/ORA team approach </textline>
<textline bbox="103.220,241.465,533.731,269.449" font="TimesNewRomanPSMT" ncolour="0" size="27.984" colourspace="DeviceGray">&#8211; Minimal reliance on Prior Approval  </textline>
</normal_text>
<normal_text id="4" bbox="103.220,167.531,610.047,195.491" size="27.96" unique_id="4">&#8211; Increased emphasis on underlying science,  <textline bbox="103.220,167.531,610.047,195.491" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8211; Increased emphasis on underlying science,  </textline>
</normal_text>
<normal_text id="3" bbox="125.780,207.851,350.299,235.811" size="27.96" unique_id="3">Supplement process <textline bbox="125.780,207.851,350.299,235.811" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">Supplement process </textline>
</normal_text>
<normal_text id="5" bbox="125.780,133.925,642.281,161.909" size="27.984" unique_id="5">mechanisms, and assessed risk of poor quality <textline bbox="125.780,133.925,642.281,161.909" font="TimesNewRomanPSMT" ncolour="0" size="27.984" colourspace="DeviceGray">mechanisms, and assessed risk of poor quality </textline>
</normal_text>
</enlisting></page>
<page id="11" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[158.42210909090906, 421.0081090909091, 567.5931818181818, 498.34354545454545]">
<title id="0" bbox="110.590,421.387,609.343,465.427" size="44.04" unique_id="0">Is Industry willing to move? <textline bbox="110.590,421.387,609.343,465.427" font="TimesNewRomanPSMT" ncolour="0" size="44.040" colourspace="DeviceGray">Is Industry willing to move? </textline>
</title>
<enlisting bbox="61.224,67.185,658.58,377.662" unique_id="['1', '  2', '  5', '  6', ' 3', '4']">&#8226; FDA is NOT the hurdle 
&#8226; FDA is working with industry minimize the &#8220;risk&#8221;  &#8226; Industry has to determine the &#8220;benefit&#8221; side of the  &#8226; Success of this initiative depends on one or two  companies who are willing to take the lead 
&#8226; Can we afford to fail or not move forward? <normal_text id="1" bbox="61.224,288.991,658.580,377.662" size="37.980000000000004" unique_id="1">&#8226; FDA is NOT the hurdle 
&#8226; FDA is working with industry minimize the &#8220;risk&#8221;  <textline bbox="61.224,329.662,540.576,377.662" font="TimesNewRomanPSMT" ncolour="0" size="48.000" colourspace="DeviceGray">&#8226; FDA is NOT the hurdle </textline>
<textline bbox="61.224,288.991,658.580,316.951" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8226; FDA is working with industry minimize the &#8220;risk&#8221;  </textline>
</normal_text>
<normal_text id="2" bbox="61.224,215.051,654.134,243.011" size="27.96" unique_id="2">&#8226; Industry has to determine the &#8220;benefit&#8221; side of the  <textline bbox="61.224,215.051,654.134,243.011" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8226; Industry has to determine the &#8220;benefit&#8221; side of the  </textline>
</normal_text>
<normal_text id="5" bbox="61.224,141.125,627.895,169.109" size="27.984" unique_id="5">&#8226; Success of this initiative depends on one or two  <textline bbox="61.224,141.125,627.895,169.109" font="TimesNewRomanPSMT" ncolour="0" size="27.984" colourspace="DeviceGray">&#8226; Success of this initiative depends on one or two  </textline>
</normal_text>
<normal_text id="6" bbox="61.224,67.185,570.953,135.461" size="27.96" unique_id="6">companies who are willing to take the lead 
&#8226; Can we afford to fail or not move forward? <textline bbox="88.224,107.501,567.151,135.461" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">companies who are willing to take the lead </textline>
<textline bbox="61.224,67.185,570.953,95.145" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">&#8226; Can we afford to fail or not move forward? </textline>
</normal_text>
<normal_text id="3" bbox="88.224,255.385,308.010,283.369" size="27.984" unique_id="3">side of the equation <textline bbox="88.224,255.385,308.010,283.369" font="TimesNewRomanPSMT" ncolour="0" size="27.984" colourspace="DeviceGray">side of the equation </textline>
</normal_text>
<normal_text id="4" bbox="88.224,181.451,184.602,209.411" size="27.96" unique_id="4">equation <textline bbox="88.224,181.451,184.602,209.411" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">equation </textline>
</normal_text>
</enlisting></page>
<page id="12" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[147.61042424242422, 429.0712575757576, 577.3783181818181, 500.85745454545463]">
<title id="0" bbox="93.552,469.387,626.304,513.427" size="44.04" unique_id="0">Meeting #3 (one day meeting) <textline bbox="93.552,469.387,626.304,513.427" font="TimesNewRomanPSMT" ncolour="0" size="44.040" colourspace="DeviceGray">Meeting #3 (one day meeting) </textline>
</title>
<enlisting bbox="67.224,39.543,665.507,434.539" unique_id="['1', '   3', '   4', '   6', '   7', '   9', '  2', ' 5', '8']">&#8226; Discussion on general principles of  &#8226; &#8220;Dry run&#8221; exercise of an mock  PAT  application, review and inspection decisions 
&#8211; Need case studies (PAT@CDER.FDA.GOV  &#8226; Issues related to rapid microbial testing &#8211; What information should be incorporated in the  &#8226; One day workshop at NIST? <normal_text id="1" bbox="67.224,402.499,553.870,434.539" size="32.04" unique_id="1">&#8226; Discussion on general principles of  <textline bbox="67.224,402.499,553.870,434.539" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Discussion on general principles of  </textline>
</normal_text>
<normal_text id="3" bbox="67.224,317.989,565.372,350.029" size="32.04" unique_id="3">&#8226; &#8220;Dry run&#8221; exercise of an mock  PAT  <textline bbox="67.224,317.989,565.372,350.029" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; &#8220;Dry run&#8221; exercise of an mock  PAT  </textline>
</normal_text>
<normal_text id="4" bbox="94.224,239.305,660.787,311.629" size="30.012" unique_id="4">application, review and inspection decisions 
&#8211; Need case studies (PAT@CDER.FDA.GOV  <textline bbox="94.224,279.589,660.787,311.629" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">application, review and inspection decisions </textline>
<textline bbox="103.220,239.305,625.238,267.289" font="TimesNewRomanPSMT" ncolour="0" size="27.984" colourspace="DeviceGray">&#8211; Need case studies (PAT@CDER.FDA.GOV  </textline>
</normal_text>
<normal_text id="6" bbox="67.224,159.569,598.309,191.609" size="32.04" unique_id="6">&#8226; Issues related to rapid microbial testing <textline bbox="67.224,159.569,598.309,191.609" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; Issues related to rapid microbial testing </textline>
</normal_text>
<normal_text id="7" bbox="103.220,119.285,665.507,147.269" size="27.984" unique_id="7">&#8211; What information should be incorporated in the  <textline bbox="103.220,119.285,665.507,147.269" font="TimesNewRomanPSMT" ncolour="0" size="27.984" colourspace="DeviceGray">&#8211; What information should be incorporated in the  </textline>
</normal_text>
<normal_text id="9" bbox="67.224,39.543,468.509,71.583" size="32.04" unique_id="9">&#8226; One day workshop at NIST? <textline bbox="67.224,39.543,468.509,71.583" font="TimesNewRomanPSMT" ncolour="0" size="32.040" colourspace="DeviceGray">&#8226; One day workshop at NIST? </textline>
</normal_text>
<normal_text id="2" bbox="94.224,364.094,615.424,396.158" size="32.064" unique_id="2">validating computer systems and models <textline bbox="94.224,364.094,615.424,396.158" font="TimesNewRomanPSMT" ncolour="0" size="32.064" colourspace="DeviceGray">validating computer systems and models </textline>
</normal_text>
<normal_text id="5" bbox="125.780,205.691,263.203,233.651" size="27.96" unique_id="5">and Docket) <textline bbox="125.780,205.691,263.203,233.651" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">and Docket) </textline>
</normal_text>
<normal_text id="8" bbox="125.780,85.665,498.375,113.625" size="27.96" unique_id="8">general guidance to address RM? <textline bbox="125.780,85.665,498.375,113.625" font="TimesNewRomanPSMT" ncolour="0" size="27.960" colourspace="DeviceGray">general guidance to address RM? </textline>
</normal_text>
</enlisting></page>
</pages>